Skip to main content
Royalty Pharma plc (RPRX)
NASDAQ: RPRX · Real-Time Price · USD
49.54
-0.11 (-0.22%)
Apr 28, 2026, 4:00 PM EDT - Market closed

Royalty Pharma Revenue

In the year 2025, Royalty Pharma had annual revenue of $2.38B with 5.06% growth. Royalty Pharma had revenue of $621.99M in the quarter ending December 31, 2025, with 4.78% growth.

Revenue (ttm)
$2.38B
Revenue Growth
+5.06%
P/S Ratio
12.35
Revenue / Employee
$23,781,930
Employees
100
Market Cap
29.37B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20252.38B114.62M5.06%
Dec 31, 20242.26B-90.98M-3.86%
Dec 31, 20232.35B117.34M5.24%
Dec 31, 20222.24B-52.25M-2.28%
Dec 31, 20212.29B167.11M7.87%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
BeOne Medicines AG 5.34B
Incyte 5.14B
argenx SE 4.24B
Genmab 3.72B
Alnylam Pharmaceuticals 3.71B
BioNTech SE 3.37B
Moderna 1.94B
Insmed 606.42M
Revenue Rankings

RPRX News

More News